On September 3, 2021, TiumBio Co., Ltd. closed the transaction. The company received the final tranche from preferred stock.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,770 KRW | +2.73% | -4.38% | -30.71% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,000 KRW | -0.18% | -2.22% | 10Cr | ||
5,510 KRW | +0.36% | +4.55% | 20Cr | ||
1st Jan change | Capi. | |
---|---|---|
-30.71% | 13Cr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr | |
+77.64% | 887.31Cr |
- Stock Market
- Equities
- A321550 Stock
- News TiumBio Co., Ltd.
- TiumBio Co., Ltd. announced that it has received KRW 49.99982815 billion in funding from Hanyang Securities Co. Ltd., EBEST Investment & Securities Co., Ltd. and other investors